tRNA modifications tune m6A-dependent mRNA decay

By Bastian Linder, Puneet Sharma, Jie Wu, Tosca Birbaumer, Cristian Eggers, Shino Murakami, Roman E. Ott, Kai Fenzl, Hannah Vorgerd, Florian Erhard, Samie R. Jaffrey, Sebastian A. Leidel and Lars M. Steinmetz

April 30, 2025

Abstract

Chemically modified nucleotides in mRNA are critical regulators of gene expression, primarily through interactions with reader proteins that bind to these modifications. Here, we present a mechanism by which the epitranscriptomic mark N6-methyladenosine (m6A) is read by tRNAs during translation. Codons that are modified with m6A are decoded inefficiently by the ribosome, rendering them “non-optimal” and inducing ribosome collisions on cellular transcripts. This couples mRNA translation to decay. 5-Methoxycarbonylmethyl-2-thiouridine (mcm5s2U) in the tRNA anticodon loop counteracts this effect. This unanticipated link between the mRNA and tRNA epitranscriptomes enables the coordinated decay of mRNA regulons, including those encoding oncogenic signaling pathways. In cancer, dysregulation of the m6A and mcm5s2U biogenesis pathways—marked by a shift toward more mcm5s2U—is associated with more aggressive tumors and poor prognosis. Overall, this pan-epitranscriptomic interaction represents a novel mechanism of post-transcriptional gene regulation with implications for human health.

Posted on:
April 30, 2025
Length:
1 minute read, 142 words
Tags:
Ribosome profiling Cancer m6A mcm5s2U
See Also:
Ncs2* mediates in vivo virulence of pathogenic yeast through sulphur modification of cytoplasmic transfer RNA
Humans and other commonly used model organisms are resistant to cycloheximide-mediated biases in ribosome profiling experiments
Dual randomization of oligonucleotides to reduce the bias in ribosome-profiling libraries